La Ligne is recalling about 1,185 sets of Enfant Bonne Nuit children's pajamas because they fail to meet federal flammability standards for children's sleepwear. These 100% cotton, two-piece long-sleeve sets were sold in six color combinations including green, pink, red, light blue, navy, and white with contrasting trim. Consumers should immediately stop using the pajamas and contact La Ligne for a refund or store credit. No incidents or injuries have been reported.
The pajamas violate mandatory flammability standards for children's sleepwear, posing a serious risk of burn injuries to children if the fabric catches fire.
Consumers should immediately take the recalled children's pajamas away from children, stop using them and contact La Ligne for a full refund. Consumers will be asked to destroy the garments by cutting them in half and disposing them. Consumers should send a photo of the destroyed garment by email to lou@lalignenyc.com to receive a refund of $75 or store credit of $100.
RN number 150209 is printed on the seam label. The neck label includes 'La Ligne' and 'Mini'.
Recalled La Ligne Enfant Bonne Nuit Pajamas in Navy with White Trim
Recalled La Ligne Enfant Bonne Nuit Pajamas in Red with White Trim
Recalled La Ligne Enfant Bonne Nuit Pajamas in Green with Light Blue Trim
Recalled La Ligne Enfant Bonne Nuit Pajamas in Pink with Red Trim
Recalled La Ligne Enfant Bonne Nuit Pajamas in White with Navy Trim
Recalled La Ligne Enfant Bonne Nuit Pajamas in Light Blue with Red Trim
Recalled La Ligne Enfant Bonne Nuit Pajamas Neck Label and Side Seam Label
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: CPSC Notice · Raw API Response